Journal Article

Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients

Trân, Kien, Fülöp, Tamàs, Sage, Michael, Sainsily, Xavier, Lamoureux, Julie, Fournier, Justin, Praud, Jean-Paul, Auger-Messier, Mannix, Sarret, Philippe, Fortin-Pellerin, Etienne, Lesur, Olivier, Marsault, Eric, Coquerel, David, Chagnon, Frédéric, Delile, Eugénie, Dumont, Audrey-Ann

2021

Overview

Sepsis is a prevalent life-threatening condition related to a systemic infection, and with unresolved issues including refractory septic shock and organ failures. Endogenously released catecholamines are often inefficient to maintain blood pressure, and low reactivity to exogenous catecholamines with risk of sympathetic overstimulation is well documented in septic shock. In this context, apelinergics are efficient and safe inotrope and vasoregulator in rodents. However, their utility in a larger animal model as well as the limitations with regards to the enzymatic breakdown during sepsis, need to be investigated. The therapeutic potential and degradation of apelinergics in sepsis were tested experimentally and in a cohort of patients. (1) 36 sheep with or without fecal peritonitis-induced septic shock (a large animal experimental design aimed to mimic the human septic shock paradigm) were evaluated for hemodynamic and renal responsiveness to incremental doses of two dominant apelinergics: apelin-13 (APLN-13) or Elabela (ELA), and (2) 52 subjects (33 patients with sepsis/septic shock and 19 healthy volunteers) were investigated for early levels of endogenous apelinergics in the blood, the related enzymatic degradation profile, and data regarding sepsis outcome. APLN-13 was the only one apelinergic which efficiently improved hemodynamics in both healthy and septic sheep. Endogenous apelinergic levels early rose, and specific enzymatic breakdown activities potentially threatened endogenous apelin system reactivity and negatively impacted the outcome in human sepsis. Short-term exogenous APLN-13 infusion is helpful in stabilizing cardiorenal functions in ovine septic shock; however, this ability might be impaired by specific enzymatic systems triggered during the early time course of human sepsis. Strategies to improve resistance of APLN-13 to degradation and/or to overcome sepsis-induced enzymatic breakdown environment should guide future works.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 631/443 / 631/45 / 692/308 / 692/4019 / 692/699 / Aged / Animal models / Animal research / Animals / Apelin - genetics / Apelin - metabolism / Biodegradation / Blood pressure / Case-Control Studies / Catecholamines / Catecholamines - metabolism / Disseminated infection / Enzymes - metabolism / Experimental design / Feces / Female / Follow-Up Studies / Hemodynamics / Humanities and Social Sciences / Humans / Male / Middle Aged / multidisciplinary / Pancreatic Elastase - genetics / Pancreatic Elastase - metabolism / Peritonitis / Peritonitis - complications / Prognosis / Prospective Studies / Proteolysis / Science / Science (multidisciplinary) / Sepsis / Septic shock / Sheep / Shock, Septic - etiology / Shock, Septic - metabolism / Shock, Septic - pathology